The structures of the new azoxy antibiotics maniwamycinsA and B have been determined by means of spectral analyses and chemical studies.
4.52 q (7.5) 1.37 d (7.5) 7.23 dd (14.0, 1.0) 6.90 dt (14.0, 7.5) 2.22 br q (7.5) From the above described data, we propose that the structure of maniwamycinA is Z-(3S)-2-oxobutane-3-AW0-azoxy-r-(iM '-hexene) as shown in Fig. 2 .
Structure of Maniwamycin B The results of FAB-MSand HREI-MSof maniwamycin B showed the formula of this antibiotic as C10H20N2O2(MW200).1} 13C NMRdata in Table 1 showed that it is constructed of ten carbon atoms classified to three C-methyls, three methylenes, two sp3 methines and two olefinic methines. Assignment of the signals for C-l, C-4, C-l', C-2' and C-3' were confirmed by the^H-13C COSY spectrum (Fig. 3) . The IR spectrum1} and *H and 13C NMRspectra indicated that maniwamycin B is a dihydro-compound of maniwamycin A at C-2.
Thus, the structure of maniwamycin B is Z-(2S,35')-2-hydroxybutane-3-iVJ/V(9-azoxyr-(£'-r-hexene) 
Geometrical and Stereochemical Studies
The oxidation of maniwamycin B with pyridinium chlorochromate afforded maniwamycin A. This suggests the same geometry of the olefin and the azoxy moiety, and the same configuration of C-3 in these antibiotics.
In the *H NMRspectra of maniwamycins A and B in CDClg,1* the signals of the olefin overlapped each other (S 7.0). Whenthe XH NMRspectrum of maniwamycin A was measured in DMSO-<i6, the signals of the olefin were less overlapped as shownin Fig. 4 . The coupling constant was able to read from the spectrum; JVt2' = 14Hz. Therefore, the olefin geometry was determined as the E configuration. It was supposed that the azoxy geometry was trans as regards carbon substituents by the UVabsorption maximum (^a°xH nm (e) 221 (5, 440) ) of the reduced derivative (H2-Rh -A12O3) ofmaniwamycin A2) and from biogenetic point of view of other known naturally occurring azoxy compounds. Stevens et al., 6) cleaved the azoxy linkage of elaiomycin by hydrogenolysis over platinum dioxide in acetic acid to get D-threonine. Under similar conditions maniwamycin B was cleaved to get (2S,3S)-3-ammo-2-butanol which was isolated as the benzyloxy-carbonyl derivative.
Only four antibiotics elaiomycin,5) LL-BH872a,4) valanimycin7) and jietacins8) have been reported to NOV. 1989 contain an azoxy moiety. Maniwamycins Aand B are newcompounds of this class and the first natural compounds possessing a £ra/ts-a,/?-unsaturated azoxy chromophore.
Experimental

General
UVspectra were recorded on a BeckmanDU-65spectrophotometer. IR spectra were obtained using a Shimadzu IR-435 spectrophotometer. MSspectra were measured on a Jeol JMS-D300mass spectrometer. Optical rotations were measured with a Jasco DIP-4 digital polarjmeter. XHand 13C NMRspectra were recorded on a Jeol GSX270 spectrometer. The chemical shifts in DMSO-d6and CDC13refer to an internal standard of TMS(Oppm).
Oxidation of ManiwamycinB Maniwamycin B (62 mg, 0.31 mmol) was dissolved in anhydrous dichloromethane (1.0 ml) with stirring, and treated with powdered molecular sieves 4A (60 mg) and pyridinium chlorochromate (200 mg, 0.93 mmol) under nitrogen at room temperature. After 10 hours, ether (5 ml) was added and the mixture was stirred for 10 minutes. The organic layer was passed through a short pad of Florisil and evaporated under reduced pressure. Chromatography of the residue on silica gel using ether-rc-hexane (1 :5) as eluent gave maniwamycin A (24mg, 40%), as a colorless oil, which was identical with the authentic product obtained from the fermentation in all respects.
Hydrogenation of Maniwamycin A To a solution of maniwamycin A (56mg, 0.28mmol) in methanol (2.0ml) was added 5% rhodium on aluminum oxide (25 mg). The mixture was stirred under hydrogen (1 atm) at room temperature for 1.5 hours. Ether (5.0 ml) was added, the suspension was filtered through Celite and the filtrate was evaporated under reduced pressure. The residue was purified by preparative TLC(silica gel, ether-rc-hexane (1 : 1) 
Hydrogenolysis of ManiwamycinB
The solution of maniwamycin B (467mg, 2.33mmol) in acetic acid (2.5ml) with platinum dioxide (106 mg) was stirred under hydrogen (1 atm) at room temperature. After 5 hours, further platinum dioxide (97mg) was added and the solution was stirred again under the same conditions for 16 hours. The mixture was filtered and the catalyst was washed with acetic acid. The combined filtrate was concentrated under reduced pressure to give crude material (ca. 1 g). This crude material was treated with diazomethane solution in ether to remove residual acetic acid. The resultant etherial solution was concentrated under reduced pressure and the residue was dissolved in anhydrous dichloromethane (5ml). To this solution, triethylamine (1.0ml, 7.2mmol ) and benzyl chloroformate (1.0ml, 7.0mmol) were added dropwise at 0°C. The reaction mixture was stirred for 30 minutes and then poured into water (20ml) and extracted with ether (75mi x 2). The extract was washed with I n hydrochloric acid (10ml), saturated aqueous sodium bicarbonate (10 ml) and brine (10 ml), and dried over anhydrous sodium sulfate. After concentration under reduced pressure, the residual material was chromatographed on silica gel using chloroform as eluent. Anal CalcdforC12H17NO3: C 64.55, H 7.67, N 6.27. Found: C 65.16, H 8.29, N 5.66 . This obtained compound was identical with the authentic (2S,3S)-7V-Cbz-3-amino-2-butanol synthesized from 7V-Cbz-D-threonine.
